Cardinal Health (NYSE:CAH) Hits New 1-Year High – Here’s What Happened

Cardinal Health, Inc. (NYSE:CAH)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $220.27 and last traded at $217.93, with a volume of 1890057 shares traded. The stock had previously closed at $218.93.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q2 results and raised outlook — Cardinal reported Q2 FY2026 revenue up ~19% to $65.6B and non‑GAAP EPS of $2.63 (beat), and raised fiscal‑year non‑GAAP EPS guidance to $10.15–$10.35; management cited strong specialty medicine demand and improved segment performance. PR Newswire
• Positive Sentiment: Analyst upgrade and price‑target lift — Leerink Partners raised its price target from $240 to $268 and kept an outperform rating, signaling more upside from current levels. MarketScreener
• Positive Sentiment: Street commentary and momentum coverage — Multiple outlets (Barron’s, Reuters, Zacks, TipRanks, 24/7 Wall St.) highlight the beat, raised guidance and accelerating specialty drug volumes, which has driven momentum interest in the stock. Examples: Reuters coverage on the outlook and Barron’s note on guidance lifts. Reuters
• Neutral Sentiment: Earnings call & transcripts available — Management commentary and slides from the Q2 call confirm the drivers behind the beat (specialty medicine, margin expansion, buybacks); these provide detail but no new surprises beyond the release. MSN Transcript
• Neutral Sentiment: Momentum stock analysis — Zacks highlights style‑score based momentum attributes, which can attract technical and quant funds but also increase volatility. Zacks
• Negative Sentiment: Valuation and historical ROE signal — After the rally the stock trades at an elevated P/E (~34x) and company data show a negative trailing return on equity metric, which could concern value‑focused investors and limit upside absent continued execution. Background valuation metrics

Wall Street Analysts Forecast Growth

Several research firms recently commented on CAH. Robert W. Baird set a $252.00 price objective on shares of Cardinal Health in a research note on Friday. Leerink Partners boosted their price target on Cardinal Health from $240.00 to $268.00 and gave the stock an “outperform” rating in a research report on Thursday. Evercore ISI restated an “outperform” rating on shares of Cardinal Health in a research note on Thursday. Argus lifted their price objective on Cardinal Health from $211.00 to $232.00 and gave the company a “buy” rating in a research note on Friday, January 23rd. Finally, Jefferies Financial Group increased their target price on Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 22nd. Fifteen analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $239.93.

Cardinal Health Stock Performance

The business’s fifty day moving average price is $206.63 and its 200-day moving average price is $179.50. The stock has a market cap of $53.90 billion, a PE ratio of 34.22, a P/E/G ratio of 1.40 and a beta of 0.64.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $65.63 billion for the quarter, compared to the consensus estimate of $64.88 billion. During the same quarter in the prior year, the firm earned $1.93 earnings per share. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. Analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Institutional Trading of Cardinal Health

A number of hedge funds have recently bought and sold shares of the company. Integrated Wealth Concepts LLC lifted its stake in shares of Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in Cardinal Health in the second quarter worth about $105,000. Simplicity Wealth LLC bought a new position in shares of Cardinal Health in the second quarter worth about $425,000. Finally, DAVENPORT & Co LLC lifted its position in shares of Cardinal Health by 28.7% during the 2nd quarter. DAVENPORT & Co LLC now owns 8,592 shares of the company’s stock valued at $1,443,000 after buying an additional 1,918 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.